| Date Filed | Type | Description |
| 06/15/2023 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Granted 12,000 options to buy
@ $1.18, valued at
$14.2k
|
|
| 06/13/2022 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Granted 12,000 options to buy
@ $2.09, valued at
$25.1k
|
|
| 10/12/2021 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on PHOENIX BIOTECH ACQUISITION CORP.|
Txns:
| Acquired 25,000 options to buy
@ $0 |
|
| 10/05/2021 |
3
| ATWOOD BRIAN G (Director) has filed a Form 3 on PHOENIX BIOTECH ACQUISITION CORP. |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2021 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Locust Walk Acquisition Corp.|
Txns:
| Disposed of 25,000 options to buy
@ $0 |
|
| 01/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/10/2020 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Gifted 12,000 options to buy
@ $17.87, valued at
$214.4k
Gifted 12,000 options to buy
@ $17.87, valued at
$214.4k
Gifted 12,500 options to buy
@ $4.56, valued at
$57k
Gifted 12,500 options to buy
@ $4.56, valued at
$57k
Gifted 34,166 options to buy
@ $12.66, valued at
$432.5k
Gifted 34,166 options to buy
@ $12.66, valued at
$432.5k
|
|
| 11/10/2020 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Exercised 6,896 options to buy
@ $3.08, valued at
$21.2k
|
|
| 06/15/2020 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Granted 12,000 options to buy
@ $17.87, valued at
$214.4k
|
|
| 06/05/2020 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 40,138 options to buy
@ $6.48, valued at
$260.1k
|
|
| 08/22/2019 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Exercised 25,862 options to buy
@ $0.29, valued at
$7.5k
|
|
| 06/24/2019 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Atreca, Inc.|
Txns:
| Converted 8,791 shares
@ $0
Converted 4,504 preferred shares
@ $0
Converted 4,287 preferred shares
@ $0 |
|
| 06/19/2019 |
3
| ATWOOD BRIAN G (Director) has filed a Form 3 on Atreca, Inc. |
| 06/07/2019 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 28,882 options to buy
@ $14.66, valued at
$423.4k
|
|
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2017 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Acquired 212 shares
@ $0
Acquired 4,998 shares
@ $0 |
|
| 06/08/2017 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 10,000 options to buy
@ $59.56, valued at
$595.6k
|
|
| 05/30/2017 |
4
| ATWOOD BRIAN G (10% Owner) has filed a Form 4 on PHASERX, INC.|
Txns:
| Granted 14,000 options to buy
@ $1.0799, valued at
$15.1k
|
|
| 06/24/2016 |
4
| ATWOOD BRIAN G (10% Owner) has filed a Form 4 on OPGEN INC |
| 06/20/2016 |
4
| ATWOOD BRIAN G (10% Owner) has filed a Form 4 on VERACYTE, INC. |
| 06/10/2016 |
4
| Versant Ventures III, LLC (10% Owner) has filed a Form 4 on Flexion Therapeutics Inc |
| 06/10/2016 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 10,000 options to buy
@ $15.23, valued at
$152.3k
|
|
| 06/03/2016 |
4
| ATWOOD BRIAN G (10% Owner) has filed a Form 4 on PHASERX, INC.|
Txns:
| Granted 28,203 options to buy
@ $5.08, valued at
$143.3k
|
|
| 06/02/2016 |
4
| VERSANT VENTURES I LLC (Former 10 % owner) has filed a Form 4 on GLAUKOS Corp |
| 05/24/2016 |
4
| ATWOOD BRIAN G (10% Owner) has filed a Form 4 on PHASERX, INC. |
| 05/24/2016 |
4
| ATWOOD BRIAN G (10% Owner) has filed a Form 4 on PHASERX, INC. |
| 05/24/2016 |
3/A
| ATWOOD BRIAN G (10% Owner) has filed a Form 3/A on PHASERX, INC. |
| 05/17/2016 |
3
| ATWOOD BRIAN G (10% Owner) has filed a Form 3 on PHASERX, INC. |
| 05/17/2016 |
3
| ATWOOD BRIAN G (10% Owner) has filed a Form 3 on PHASERX, INC. |
| 01/06/2016 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Immune Design Corp.|
Txns:
| Granted 9,300 options to buy
@ $19.39, valued at
$180.3k
|
|
| 06/30/2015 |
4
| VERSANT VENTURES I LLC (10% Owner) has filed a Form 4 on GLAUKOS Corp|
Txns:
| Converted 2,868,959 shares
@ $0
Exercised 27,612 shares
@ $0
Paid exercise price by delivering 11,736 shares
@ $18, valued at
$211.2k
Converted 61,886 shares
@ $0
Exercised 577 shares
@ $0
Paid exercise price by delivering 246 shares
@ $18, valued at
$4.4k
Converted 131,738 shares
@ $0
Exercised 1,296 shares
@ $0
Paid exercise price by delivering 551 shares
@ $18, valued at
$9.9k
Converted 56,379 shares
@ $0
Exercised 552 shares
@ $0 |
|
| 06/16/2015 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 12,500 options to buy
@ $22.15, valued at
$276.9k
|
|
|